These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 32644844)

  • 1. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
    Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K
    DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
    Zha Z; Zhang P; Li D; Liu G; Lu L
    Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
    Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
    Front Genet; 2022; 13():794621. PubMed ID: 36313430
    [No Abstract]   [Full Text] [Related]  

  • 11. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
    Cheng P
    J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
    Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
    Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.